Full-Time

ERP Functional Expert Intercompany

Posted on 5/11/2026

Deadline 6/11/26
Opella

Opella

1,001-5,000 employees

No salary listed

Hyderabad, Telangana, India

In Person

Category
IT & Security (1)
Required Skills
SAP Products
Requirements
  • 8+ years doing ERP delivery in a business-oriented context, preferably in an FMCG global company
  • Solid experience in implementing and maintaining SAP Materials Management and Sales and Distribution modules
  • Knowledge on plant abroad, and trading company concepts
  • Knowledge on application integrations
  • Solid configuration experience, ability to determine when to use configuration vs. code, as well as good troubleshooting skills
  • Good communication skills, both written and verbal
Responsibilities
  • Serve as the subject-matter expert for SAP Intercompany Logistics, in collaboration with the functional expert for SAP Intercompany Finance.
  • Perform functional and technical analysis, research, design, and development of functionalities, including integration with key applications, in an SAP ecosystem.
  • Ensure SAP solutions follow company standards, industry best practices, and GxP requirements where applicable.
  • Collaborate with plant teams and global supply chain stakeholders to understand business needs.
  • Develop a solid understanding of Opella business processes and strategy through collaboration and regular engagement with key users and process owners
  • Critically evaluate information gathered from multiple sources, break high-level requirements into details, and distinguish user requests from underlying needs, translating these into documented solutions
  • Work closely with colleagues responsible for end-to-end Intercompany flows in the global supply chain (including financial and trading entities) to ensure coherent end-to-end processes.
  • Support cross-functional design and troubleshooting in integrated scenarios (e.g.site logistics operations, financial flows).
  • Support development team with the resolution of blocking issues and interdependencies, and provide design guidance
  • Collaborate with other functional experts and business analysts to ensure end-to-end process integration and consistency, ensuring coverage of operational, statutory, and legal requirements.
  • Collaborate with the development team to develop, configure, and implement the solution as per the product development standards to meet business requirements
  • Contribute to global and site-level implementation projects, upgrades, and template rollouts.
  • Review and challenge proposals from external system integrators to secure adherence to Opella standards and alignment with business requirements while ensuring scalability and maintainability.
  • Provide Level 3 expert support for intercompany topics
  • Collaborate with technical teams (ABAP, Basis, security) and external partners when required.
  • Ensure issues are resolved with the right balance of speed, quality, and sustainability.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Neuilly-sur-Seine, France

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • ARENA grants $1.94M for Queensland site electrification, cutting Scope 1 emissions.
  • Navan partnership targets 20% travel cost savings and 95% adoption rate.
  • Opella achieved €5B revenues in 2024 as self-care market leader.

What critics are saying

  • KKR's €2.6B Karo Healthcare buyout erodes Opella's European OTC share.
  • French backlash forces Doliprane divestiture, disrupting core domestic sales.
  • CD&R cost-cutting triggers layoffs of 11,000 employees within 12 months.

What makes Opella unique

  • Opella holds third-largest global OTC and VMS portfolio with 100 brands.
  • Opella operates 13 manufacturing sites and 4 innovation centers worldwide.
  • Opella became independent via CD&R's €10B buyout from Sanofi in April 2025.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Opella who can refer or advise you

Benefits

Hybrid Work Options

Company News

Carroll County News
Apr 15th, 2026
Navan selected by Opella to streamline global travel and expense.

Navan selected by Opella to streamline global travel and expense. * 1 hr ago Navan (NASDAQ: NAVN), the global AI-powered business travel and expense management platform, today announced it has been selected by Opella to manage its global travel and expense programme. Self-care company aims to simplify employee T&E experience and targets cost savings with AI-powered platform "Navan provides our teams with an easy-to-use tool that removes the complexity from business travel and expense, improving our employee experience and giving us the real-time visibility required to effectively manage costs," said Vincent Cotard, VP Global Head Real Estate and Workplace Experience at Opella. "Our employees will now have the easiest way to book travel and manage their expenses as we look to automate processes across the business." Following Opella's carve-out from Sanofi, the self-care company sought an AI-powered partner to provide employees with an easy-to-use travel platform and to optimize spending. Initial conversations began about Navan's travel product and Opella extended the partnership to also include Navan's expense product, giving them end-to-end control and visibility of their entire travel and expense outlay. Anticipated benefits from the partnership with Navan include: * Cost savings: Targeting savings of up to 20% on annual travel spend through access to competitive pricing and reduced fees. * High adoption: Aiming for 95% platform adoption and a 96% traveller satisfaction score. * Operational efficiency: Saving an estimated 15 minutes per booking through AI-assisted capabilities and improved self-serve access across both web and mobile applications. "We're thrilled to partner with Opella to modernise their global travel and expense programme," said Zahir Abdelouhab, SVP, EMEA, Navan. "By addressing issues with their existing inventory, we are confident that Opella will achieve the adoption rates and savings necessary to meet their goals." Opella joins a growing list of enterprise organizations that have recently switched to Navan, including industry leaders from across France, including Alcatel-Lucent, Lafarge, and Expleo. About Opella Opella is the self-care challenger with the purest and third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Its mission is to bring health into people's hands by making self-care as simple as it should be. For half a billion consumers worldwide - and counting. At the core of this mission is its 100 loved brands, its 11,000-strong global team, its 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world's most loved brands, including Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale and Mucosolvan. B Corp certified globally, Mycarrollcountynews is active players in the journey towards healthier people and planet. About Navan Navan (NASDAQ: NAVN) is the global AI-powered business travel and expense platform that makes travel easy for frequent travelers. From finding flights and hotels, to automating expense reconciliation, with 24/7 support along the way, Navan delivers an intuitive experience travelers love and finance teams rely on. See how Navan customers benefit and learn more at navan.com. Forward Looking Statements All statements in this press release other than statements of historical fact could be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "project," "will," or similar expressions. Such statements are subject to risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. These risks and other factors include the risks described under the caption "Risk Factors" in Navan's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on April 2, 2026, as they may be updated by Navan's subsequent filings with the SEC. Except as required by law, Navan undertakes no obligation, and does not intend, to update these forward-looking statements. Media gallery

The Australian Pipeliner
Mar 23rd, 2026
$13 million boost for industrial decarbonisation.

$13 million boost for industrial decarbonisation. Image: zhengzaishanchu/stock.adobe.com The Australian Renewable Energy Agency (ARENA) has announced a $13 million funding package to support five projects aimed at cutting emissions across Australian industry. The investment, delivered through ARENA's National Industrial Transformation program, will back technologies designed to reduce emissions, lower long-term energy costs and strengthen low-carbon supply chains. ARENA CEO Darren Miller said decarbonising industry is critical to achieving Australia's net zero targets and requires early-stage support to unlock wider private investment. "Australia cannot reach net zero without transforming how we produce the materials, energy and goods that underpin our economy," he said. "These projects show that industrial decarbonisation is not a future aspiration but is happening now, with practical solutions that cut emissions, strengthen competitiveness and build the foundations for new low-carbon industries." Projects include: * 4 Pines Brewing Co will receive up to $1.77 million in ARENA funding to support the electrification of its Brookvale brewhouse, enabling a transition away from natural gas and positioning the site among the most advanced low-carbon breweries in Australia. * Alsco will receive up to $1.04 million to deliver its South Coast Flagship Site for Innovation and Low Carbon Demonstration, an industry-leading showcase of clean technology for automated laundry sorting and washing that reduces energy, time and resource use. * Opella Healthcare will receive up to $1.94 million to eliminate natural gas use at its Queensland manufacturing site, cutting Scope 1 emissions while maintaining essential production conditions, including temperature, humidity and water flow. * Capral will receive up to $3.45 million to replace a 40-year-old gas-fired log furnace with a fully electric furnace system at its Bremer Park aluminium extrusion facility in Queensland. The new electrically heated convection oven is expected to improve efficiency from 20% to 90% and reduce company-wide emissions. * BioCarbon will receive up to $4.80 million to construct a commercial-scale facility producing biochar pellets to replace fossil coke in electric arc furnace steelmaking. Once operational, the facility will process approximately 20,000 tonnes of waste woodchips each year to produce around 8,000 tonnes of biochar pellets and 8,000 tonnes of wood vinegar as a co-product. ARENA said the projects highlight the growing momentum of industrial decarbonisation in Australia, with initiatives already underway to electrify processes, improve efficiency and adopt low-emissions technologies across key industries

Wamda
Sep 30th, 2025
Turbostart leads $2 million round in Climaty AI

* India-founded and UAE-based climatetech Climaty AI has raised $2 million in early-stage funding led by Turbostart, with participation from AI experts and angel investors.

PR Newswire
Jun 16th, 2025
Cortizone-10® Partners With Dylan Efron And The National Park Foundation To Help Outdoor Enthusiasts Stay Itch-Free This Summer

The brand's new Itch Relief Cooling Spray helps tackle "itchsanity" one irritation at a time.MORRISTOWN, N.J., June 16, 2025 /PRNewswire/ -- Whether it's a weekend hike, a summer camping trip, or just time spent in the backyard, skin irritations can take the fun out of outdoor activities. That's why Cortizone-10®, the #1 Doctor Recommended OTC Topical Anti-Itch Brand*, is teaming up with the National Park Foundation and outdoor advocate Dylan Efron this summer to help more people enjoy nature—without the itch

PitchBook
Jun 5th, 2025
Opella's €8B Buyout Boosts PE Deals

PE investment in Europe's healthcare sector reached €15.4 billion in Q1, driven by large-cap buyouts. Two-thirds of this value came from two major deals: Clayton, Dubilier & Rice's €8 billion buyout of Opella and KKR's €2.6 billion acquisition of Karo Healthcare. This marks a 40% increase from the previous year. Despite the high deal value, deal volume dropped to 119 from 162 and 155 in Q3 and Q4 2024, respectively, as PE investment focuses on fewer, larger deals.